AstraZeneca PLC (AZN) Yield on Cost (YOC): 1.76%
The yield on cost (YOC) for AstraZeneca PLC (AZN) is 1.76%.
AZN Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
1.76%
Yield on Cost for AZN
AZN now pays $3.20 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-06-09) | $57.92 | 5.52% |
| 5 years ago(2021-06-07) | $112.50 | 2.84% |
| 3 years ago(2023-06-07) | $146.90 | 2.18% |
| 1 year ago(2025-06-11) | $148.22 | 2.16% |
| Buying today(at $182.28) | $182.28 | 1.76% |
If you buy today and the dividend keeps growing
Projection: starting from today's 1.76% yield, assuming the dividend keeps compounding at its historical 2.5% rate. Boards set dividends each year, so actual figures will differ.
Today
1.76%
In 3 years
1.95%
In 5 years
2.10%
In 10 years
2.51%
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for AstraZeneca PLC (AZN).
Starting Yield
1.76%
Ending YOC
2.53%
Year 15 Dividend
$4.61
Cum. Dividends Recd.
$58.67
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $3.20 | — | 1.76% | $0.00 |
| Year 1 | $3.28 | +2.47% | 1.80% | $3.28 |
| Year 2 | $3.36 | +2.47% | 1.84% | $6.64 |
| Year 3 | $3.44 | +2.47% | 1.89% | $10.08 |
| Year 4 | $3.53 | +2.47% | 1.94% | $13.61 |
| Year 5 | $3.62 | +2.47% | 1.98% | $17.23 |
| Year 6 | $3.70 | +2.47% | 2.03% | $20.93 |
| Year 7 | $3.80 | +2.47% | 2.08% | $24.73 |
| Year 8 | $3.89 | +2.47% | 2.13% | $28.62 |
| Year 9 | $3.99 | +2.47% | 2.19% | $32.60 |
| Year 10 | $4.08 | +2.47% | 2.24% | $36.69 |
| Year 11 | $4.19 | +2.47% | 2.30% | $40.87 |
| Year 12 | $4.29 | +2.47% | 2.35% | $45.16 |
| Year 13 | $4.39 | +2.47% | 2.41% | $49.55 |
| Year 14 | $4.50 | +2.47% | 2.47% | $54.06 |
| Year 15 | $4.61 | +2.47% | 2.53% | $58.67 |
AstraZeneca PLC Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
AstraZeneca PLC Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for AstraZeneca PLC (AZN)?
- The yield on cost (YOC) for AZN stock is 1.76%.
About AstraZeneca PLC
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Pascal Claude Roland Soriot